Basic waveform capnography as a continuous monitoring tool during mechanical ventilation

15.07.2021
Author: Joe Hylton, MA, BSRT, RRT-ACCS/NPS, NRP, FAARC, FCCM, Clinical Applications Specialist, Hamilton Medical Inc., Reviewer: Munir Karjahgli, Jean-Michel Arnal

Waveform capnography is no stranger to intensive care/critical care medicine. It is a widely utilized airway management validation tool and is used extensively in the conscious sedation environment, as well as during interfacility transport of intubated patients requiring mechanical ventilation.  Waveform capnography can provide timely, valuable information to a well-trained caregiver.

Physiologic factors affecting end-tidal carbon dioxide (PetCO2)

There are many factors that may affect the amount of carbon dioxide in the end-tidal gas (PetCO2). For the elimination of CO2, there is a close, continuous balance between the production of CO2 in the tissues, its transport in the blood, diffusion into the alveoli, and elimination by ventilation (1). Capnography provides a graphical representation of expired CO2 and serves as a noninvasive means of displaying real-time information about the CO2 kinetics in mechanically ventilated patients.

An increase or decrease in the patient's metabolic rate will lead to a change in CO2 production and, therefore, CO2 elimination as well. If both circulation and ventilation are stable - a state which can only be achieved in passive mechanically ventilated patients - CO2 monitoring can be used as an indicator of CO2 production. Fever, sepsis, pain, and seizures are all conditions that increase metabolism, causing a corresponding increase in CO2 production and, in turn, an increase in PetCO2. A decrease in metabolism occurs in patients who are hypothermic, or sedated and paralyzed. This lowers the production of CO2 and may lead to a decrease in PetCO2 if the minute ventilation does not increase at the same time (2).

The transport of CO2 to the lungs relies on proper cardiovascular function; therefore, any factor that alters cardiovascular function may also influence CO2 transport to the lungs (2).

The removal of CO2 from the lungs to the environment is affected by changes in respiratory function. Obstructive lung diseases, pneumonia, neuromuscular disorders, and central nervous system disorders that result in impaired respiratory function will therefore effect a change in PetCO2 value (2).

Types of capnography

The measured CO2 signal can be recorded either as a function of time (time-based capnography) or expired volume (volumetric capnography). The amount of information potentially offered by these two different types of capnography varies significantly. Certain patterns in a time-based capnogram that are considered typical for specific clinical situations have been described in the literature. Some of the common ones are shown below.

However, time-based capnography also has limitations: It cannot provide an accurate estimate of the lung’s ventilation-perfusion status, nor can it be used to estimate the component of physiologic dead space. While not as simple and convenient as time-based capnography, volumetric capnography has the advantage of offering considerably more information.

The volumetric capnogram – shape and phases

The normal shape of a volumetric capnogram consists of three phases. It is important to remember that the capnogram is representative of exhalation.  Phase I represents the gas without CO2 from the airways (anatomical and instrument dead space). Phase II is a transitional phase, where gas from the conductive airways is mixed with alveolar gas. Phase III is a plateau phase, consisting of gas from alveoli and slow-emptying lung areas (2). A visual representation is shown below.

Capnography during transport

Capnography, whether time-based or volumetric, can provide valuable information to optimize monitoring and guide care in the patient requiring intrahospital/interhospital transport. It can be safely utilized with endotracheal tubes, tracheostomy tubes, and many supraglottic airways, provided an effective seal is present. Airway placement and patency, ventilation monitoring, and perfusion status are all areas where PetCO2 provides significant information. Another valuable parameter is the volume of carbon dioxide eliminated per minute (V'CO2), which allows caregivers to assess effective perfusion and volume resuscitative efforts (3).

Capnography in the ICU

In the intensive care unit, waveform capnography can continue monitoring of airway placement and patency, with various airway adjuncts. The dead space to tidal volume ratio (VD/Vt) is an important capnography measurement.  An increasing VD/Vt ratio can represent a potential increase in mortality, based on the level of increase (4, 5). Caregivers may utilize the PetCO2 waveform and V’CO2 to optimize lung recruitment, to validate optimal PEEP adjustments, and to identify issues with perfusion (systemic and pulmonary) (4, 5, 6, 7). V’CO2 can also be utilized during liberation of mechanical ventilation, allowing caregivers to identify potential patient tiring/failure (increasing dead space fraction, inadequate effort, and respiratory muscle tiring). Energy expenditure derived from V’CO2 is an accurate and precise method that caregivers can utilize to calculate nutritional requirements for mechanically ventilated patients (8).

All Hamilton Medical ventilators provide volumetric capnography*, either as a standard or optional feature. The CO2 measurement is performed using a CAPNOSTAT® 5 mainstream CO2 sensor at the patient‘s airway opening. In addition, they offer an overview of all relevant CO2-related values in the Monitoring CO2 window.

* All models except HAMILTON-MR1

References

  1. Kremeier, Peter & Bohm, Stephan & Tusman, Gerardo. (2020). Clinical use of volumetric capnography in mechanically ventilated patients. Journal of Clinical Monitoring and Computing. (2020) 34:7–16
  2. Gravenstein, J., Jaffe, M., & Paulus, D. (2004). Capnography: Clinical Aspects. New York: Cambridge University Press.
  3. El-Gnaidy, E., Abo El-Nasr, L., Ameen, S., & Abd El-Ghafar, M. (2019). Correlation between Cardon Dioxide Production and Mean Arterial Blood Pressure in Fluid Response in Mechanically Ventilated Patients. Medical Journal of Cairo University, 87(4), 2679-2684.
  4. Kallet, R., Alonso, J., Pittet, J., & Matthay, M. (2004). Prognostic Value of the Pulmonary Dead-Space Fraction During the First 6 Days of Acute Respiratory Distress Syndrome. Respiratory Care, 49(9), 1008-1014.
  5. Nuckton, T., Alonso, J., Kallet, R., Daniel, B., Pittet, J., Eisner, M., & Matthay, M. (2002, April 25). Pulmonary Dead-Space Fraction as a Risk Factor for Death in the Acute Respiratory Distress Syndrome. New England Journal of Medicine, 346, 1281-1286.
  6. Blankman, P., Shono, A., Hermans, B., Wesselius, T., Hasan, D., & Gommers, D. (2016). Detection of optimal PEEP for equal distribution of tidal volume by volumetric capnography and electrical impedance tomography during decreasing levels of PEEP in post cardiac-surgery patients. British Journal of Anesthesia, 116(6), 862-869.
  7. Nguyen, L., & Squara, P. (2017). Non-invasive Monitoring of Cardiac Output in Critical Care Medicine. Frontiers in Medicine, 4(200), 1-10.
  8. Stapel, S., de Grooth, H., Alimohamad, H., Elbers, P., Girbes, A., Weijs, P., & Oudemans-van Stratten, H. (2015, 1-10). Ventilator-derived carbon dioxide production to assess energy expenditure in critically ill patients: proof of concept. Critical Care, 19(370).

Related Articles

capnography, volumetric capgnography, time-based capnography, co2 monitoring, petco2, expired gas, metabolism, co2 elimination
Back

Date of Printing: 30.06.2022
Disclaimer:
The content of this newsletter is for informational purposes only and is not intended to be a substitute for professional training or for standard treatment guidelines in your facility. Any recommendations made in this newsletter with respect to clinical practice or the use of specific products, technology or therapies represent the personal opinion of the author only, and may not be considered as official recommendations made by Hamilton Medical AG. Hamilton Medical AG provides no warranty with respect to the information contained in this newsletter and reliance on any part of this information is solely at your own risk.
Date of Printing: 30.06.2022
Disclaimer:
The content of this Knowledge Base is intended for informational purposes only. Medin Medical AG provides no warranty with respect to the information contained in this Knowledge Base and reliance on any part of this information is solely at your own risk. For detailed instructions on operating your Medin Medical device, please refer to the official Medin Medical Operator’s Manual for the respective device.